Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for NDA 021527

ATROVENT HFA (IPRATROPIUM BROMIDE)
0.021MG/INH Marketing Status: Prescription

Active Ingredient: IPRATROPIUM BROMIDE
Proprietary Name: ATROVENT HFA
Dosage Form; Route of Administration: AEROSOL, METERED; INHALATION
Strength: 0.021MG/INH
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: 
Application Number: N021527
Product Number: 001
Approval Date: Nov 27, 2004
Applicant Holder Full Name: BOEHRINGER INGELHEIM PHARMACEUTICALS INC
Marketing Status:  Prescription
Patent and Exclusivity Information

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English